← Back to screener

Organon & Co. OGN

Rank #1347 · NYSE · $3.6B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
49.6
P/E
3.6
P/B
-4.07
ROE
-114.7%
Op. Margin
–%
Debt Ratio
-1416%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 3.6x, P/B -4.07x. Ranks in the top 50% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -114.7%. Ranks in the top 95% of the universe.

Safety ★★★★★
Excellent

Debt ratio -1416%. Ranks in the top 2% of the universe. Under 100% is generally considered a safe level.

Growth ★★☆☆☆
Average

Revenue growth of 1.4% year over year. Ranks in the top 60% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2021$7.8B–$3.2B$6.3B–59
2022$6.5B–$2.2B$7.0B–52
2023$6.3B–$1.4B$5.5B–216
2024$6.2B–$0.9B$-1.5B–-804
2025$6.3B–$1.0B$-0.9B–-1416

← See the full screener